Update in Pituitary 2010 | Zendy

Janet Schlechte | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Update in Pituitary 2010

Author(s) -

Janet Schlechte

Publication year - 2011

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2010-2410

Subject(s) - cabergoline , pegvisomant , acromegaly , medicine , endocrine system , dopamine agonist , endocrine disease , hypopituitarism , agonist , pituitary adenoma , pituitary tumors , pediatrics , growth hormone , hormone , prolactin , adenoma , receptor

This manuscript is based on an invited lecture entitled "The Year in Pituitary," presented at the 91st Annual Meeting of The Endocrine Society in San Diego, California, on June 21, 2010. The purpose of the lecture was to highlight new or evolving issues in the management of pituitary disease. Papers selected were published in major journals between January 2009 and June 2010. Issues addressed include the safety of cabergoline in pregnancy, recurrence of hyperprolactinemia after dopamine agonist withdrawal, pegvisomant and hepatic dysfunction, and high-dose hydrocortisone as a predictor of mortality in patients with acromegaly.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research